CA2921187A1 - Method for enhancing tumor growth - Google Patents

Method for enhancing tumor growth Download PDF

Info

Publication number
CA2921187A1
CA2921187A1 CA2921187A CA2921187A CA2921187A1 CA 2921187 A1 CA2921187 A1 CA 2921187A1 CA 2921187 A CA2921187 A CA 2921187A CA 2921187 A CA2921187 A CA 2921187A CA 2921187 A1 CA2921187 A1 CA 2921187A1
Authority
CA
Canada
Prior art keywords
cells
human
mammal
stem cells
nme7
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA2921187A
Other languages
English (en)
French (fr)
Inventor
Cynthia C. Bamdad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Minerva Biotechnologies Corp
Original Assignee
Minerva Biotechnologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2014/017515 external-priority patent/WO2014130741A2/en
Application filed by Minerva Biotechnologies Corp filed Critical Minerva Biotechnologies Corp
Publication of CA2921187A1 publication Critical patent/CA2921187A1/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0271Chimeric vertebrates, e.g. comprising exogenous cells
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00Modified animals
    • A01K2207/12Animals modified by administration of exogenous cells
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00Modified animals
    • A01K2207/15Humanized animals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • A01K2227/105Murine
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/03Animal model, e.g. for test or diseases
    • A01K2267/0331Animal model for proliferative diseases

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Compounds Of Unknown Constitution (AREA)
CA2921187A 2013-08-12 2014-08-12 Method for enhancing tumor growth Pending CA2921187A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361865092P 2013-08-12 2013-08-12
US61/865,092 2013-08-12
USPCT/US14/17515 2014-02-20
PCT/US2014/017515 WO2014130741A2 (en) 2013-02-20 2014-02-20 Nme inhibitors and methods of using nme inhibitors
PCT/US2014/050773 WO2015023694A2 (en) 2013-08-12 2014-08-12 Method for enhancing tumor growth

Publications (1)

Publication Number Publication Date
CA2921187A1 true CA2921187A1 (en) 2015-02-19

Family

ID=52468797

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2921187A Pending CA2921187A1 (en) 2013-08-12 2014-08-12 Method for enhancing tumor growth

Country Status (8)

Country Link
EP (2) EP4233536B1 (enExample)
JP (2) JP6640086B2 (enExample)
CN (1) CN105764334B (enExample)
AU (2) AU2014306778B2 (enExample)
CA (1) CA2921187A1 (enExample)
IL (1) IL244093B (enExample)
TW (1) TWI659210B (enExample)
WO (1) WO2015023694A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3352566A4 (en) * 2015-09-23 2019-07-31 Minerva Biotechnologies Corporation SCREENING METHOD FOR ACTIVE SUBSTANCES FOR DIFFERENTIATING STEM CELLS
IL302144A (en) 2017-03-29 2023-06-01 Minerva Biotechnologies Corp Agents for stem cell differentiation and cancer treatment
CN108434452A (zh) * 2018-03-13 2018-08-24 安徽瀚海博兴生物技术有限公司 一种将pd-1抗体和jmjd6联合用于制备抗癌药物的应用
KR20230028796A (ko) 2020-06-26 2023-03-02 미네르바 바이오테크놀로지 코포레이션 항-nme 항체 및 암 또는 암 전이의 치료 방법
AU2023253692A1 (en) 2022-04-12 2024-11-14 Minerva Biotechnologies Corporation Anti-variable muc1* antibodies and uses thereof
WO2025049494A1 (en) 2023-08-29 2025-03-06 Minerva Biotechnologies Corporation Bacterial nme7 orthologs and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8562988B2 (en) * 2005-10-19 2013-10-22 Ibc Pharmaceuticals, Inc. Strategies for improved cancer vaccines
CA2656548A1 (en) * 2005-06-30 2007-01-11 Whitehead Institute Progenitor cells and uses thereof
CN101501187A (zh) * 2006-06-06 2009-08-05 田纳西大学研究基金会 富含赘生干细胞的组合物及包含其的方法
AU2008207945A1 (en) * 2007-01-22 2008-07-31 Macrogenics West, Inc. Human cancer stem cells
US11898160B2 (en) * 2008-10-09 2024-02-13 Minerva Biotechnologies Corporation Method for maintaining pluripotency in cells
CA2830503A1 (en) * 2011-03-17 2012-09-20 Minerva Biotechnologies Corporation Method for making pluripotent stem cells
US10731134B2 (en) * 2011-05-27 2020-08-04 Public University Corporation Yokohama City University Production method for artificial cancer stem cell and induced differentiation method therefor
EP2768945B1 (en) * 2011-10-17 2022-01-05 Minerva Biotechnologies Corporation Media for stem cell proliferation and induction
TW201335372A (zh) * 2011-11-30 2013-09-01 Nat Cancer Ct 誘導惡性幹細胞
AU2013295811A1 (en) * 2012-07-24 2015-03-12 Minerva Biotechnologies Corporation NME variant species expression and suppression
IL307628A (en) * 2013-02-20 2023-12-01 Minerva Biotechnologies Corp Nme inhibitors and methods of using nme inhibitors

Also Published As

Publication number Publication date
JP2019213551A (ja) 2019-12-19
AU2014306778A1 (en) 2016-03-03
WO2015023694A3 (en) 2015-04-23
JP6902577B2 (ja) 2021-07-14
IL244093A0 (en) 2016-04-21
AU2014306778B2 (en) 2020-10-29
TW201537172A (zh) 2015-10-01
EP3038462A4 (en) 2017-06-14
IL244093B (en) 2022-01-01
AU2021200429B2 (en) 2023-05-11
TWI659210B (zh) 2019-05-11
EP3038462B1 (en) 2023-03-15
WO2015023694A2 (en) 2015-02-19
CN105764334B (zh) 2020-07-28
EP4233536B1 (en) 2025-12-31
EP4233536A2 (en) 2023-08-30
EP3038462A2 (en) 2016-07-06
CN105764334A (zh) 2016-07-13
JP6640086B2 (ja) 2020-02-05
AU2021200429A1 (en) 2021-02-25
JP2016527901A (ja) 2016-09-15
AU2021200429C1 (en) 2023-11-30
EP4233536A3 (en) 2023-10-25

Similar Documents

Publication Publication Date Title
US20220193270A1 (en) Method for enhancing tumor growth
AU2021200429C1 (en) Method for enhancing tumor growth
JP6602745B2 (ja) 非胚性幹細胞の単離とその使用
JP2017525351A (ja) 多能性幹細胞の培養用培地
KR102116794B1 (ko) 분화다능성 줄기세포의 제조방법
CN109456932A (zh) 用于干细胞增殖和诱导的培养基
JP7307481B2 (ja) 始原生殖細胞/始原生殖細胞様細胞の維持増幅及び分化誘導方法
CN104350145A (zh) 用于无饲养细胞培养牛和猪的精原干细胞的方法
US20180258186A1 (en) NME Inhibitors and Methods of Using NME Inhibitors
AU2016287603A1 (en) Method of stem cell-based organ and tissue generation
CN102816739B (zh) c-Jun的截短型维持胚胎干细胞多能性的方法和应用
Abdelhay et al. Networks Establishing Hematopoietic Stem Cell Multipotency and Self-Renewal

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20171229

EEER Examination request

Effective date: 20171229

EEER Examination request

Effective date: 20171229

EEER Examination request

Effective date: 20171229

EEER Examination request

Effective date: 20171229

EEER Examination request

Effective date: 20171229

EEER Examination request

Effective date: 20171229

EEER Examination request

Effective date: 20171229